We leveraged the largely untapped resource of electronic health record data to address critical
clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To …

Objective Preliminary data from different cohorts of small sample size or with short follow‐up
indicate poorer prognosis in people with obesity compared with other patients. This study …

Several medications commonly used for a number of medical conditions share a property of
functional inhibition of acid sphingomyelinase (ASM), or FIASMA. Preclinical and clinical …

Background BaMaRa allows the secure collection and deidentified centralization of medical
data from all patients followed-up in a rare disease expert network in France, based on a …

Background In France, the Ministry of Health has implemented a comprehensive program for
rare diseases (RD) that includes an epidemiological program as well as the establishment …

Background Prior research suggests that psychiatric disorders could be linked to increased
mortality among patients with COVID-19. However, whether all or specific psychiatric …

Background Preliminary data suggest that COVID-19 pandemic has generated a switch from
face-to-face to remote care for individuals with chronic diseases. However, few data are …

In France, all patients followed by Rare Disease (RD) expert centers have to be registered
in the National Rare Disease Registry (BNDMR). This database collects a minimum data set …

Background Children with rare bone diseases (RBDs), whether medically complex or not,
raise multiple issues in emergency situations. The healthcare burden of children with RBD in …

French data on the epidemiology and expert healthcare network for epidermolysis bullosa -
Inria - Institut national de recherche en sciences et technologies du numérique Accéder …